The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 208-210, July 2007

Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults

  • Stephen B. Gordon, FRCP

      Affiliations

    • From the Malawi-Liverpool-Wellcome Programme for Research in Tropical Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi
    • School of Tropical Medicine, Liverpool, United Kingdom
    • Corresponding Author InformationReprint requests: Stephen B. Gordon, FRCP, School of Tropical Medicine, Liverpool L3 5QA, United Kingdom.
    • ,
  • Helena Kayhty, PhD

      Affiliations

    • Vaccine Immunology Laboratory, National Public Health Institute, Helsinki, Finland
    • ,
  • Malcolm E. Molyneux, FRCP

      Affiliations

    • From the Malawi-Liverpool-Wellcome Programme for Research in Tropical Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi
    • School of Tropical Medicine, Liverpool, United Kingdom
    • ,
  • Raili Haikala, BSc

      Affiliations

    • Vaccine Immunology Laboratory, National Public Health Institute, Helsinki, Finland
    • ,
  • Anu Nurkka, PhD

      Affiliations

    • Vaccine Immunology Laboratory, National Public Health Institute, Helsinki, Finland
    • ,
  • Janelisa Musaya, MSc

      Affiliations

    • From the Malawi-Liverpool-Wellcome Programme for Research in Tropical Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi
    • ,
  • Eduard E. Zijlstra, MD

      Affiliations

    • Department of Medicine, University of Malawi College of Medicine, Blantyre, Malawi
    • ,
  • Dennis Lindell, PhD

      Affiliations

    • Department of Pathology, University of Michigan, Ann Arbor, Mich
    • ,
  • Neil French, FRCP

      Affiliations

    • From the Malawi-Liverpool-Wellcome Programme for Research in Tropical Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi
    • Department of Medicine, University of Malawi College of Medicine, Blantyre, Malawi

published online 04 June 2007.

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Supported by the Wellcome Trust of Great Britain (SG grant 061231, NF grant 061230, and MEM grant 058390).Disclosure of potential conflict of interest: H. Kayhty has received grant support from GlaxoSmithKline and Wyeth; has acted in external scientific boards for GlaxoSmithKline; and has received honoraria from GlaxoSmithKline. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)00754-3

doi:10.1016/j.jaci.2007.03.050

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 208-210, July 2007

Article Tools